Preview: Actuate Therapeutics, Inc Set To IPO Tomorrow

Actuate Therapeutics, Inc ACTU IPO will take place July, 25 on the NASDAQ exchange under the ticker ACTU.

The company is offering shares at an expected price between $8.00 and $10.00 per share with an insider lock-up period of 180 days ending on January 21, 2025.

See also: Benzinga IPO Calendar

About Actuate Therapeutics, Inc

Actuate Therapeutics, Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.